faronoltinib   Click here for help

GtoPdb Ligand ID: 10549

Synonyms: compound 18e [PMID: 31670517]
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Compound 18e is an optimised, orally bioavailable dual Janus kinase 2 (JAK2)/fms related tyrosine kinase 3 (FLT3) inhibitor [1]. It exhibits anti-tumour activity in vitro and in vivo. The chemical structure was matched to that for the INN faronoltinib, as disclosed in WHO INN Proposed List 135 (July 2026).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 82.34
Molecular weight 467.28
XLogP 3.48
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCCN(C1CCN(CC1)c1ccc(cc1F)Nc1ncc(c(n1)c1cnn(c1)C(C)C)C)C
Isomeric SMILES OCCN(C1CCN(CC1)c1ccc(cc1F)Nc1ncc(c(n1)c1cnn(c1)C(C)C)C)C
InChI InChI=1S/C25H34FN7O/c1-17(2)33-16-19(15-28-33)24-18(3)14-27-25(30-24)29-20-5-6-23(22(26)13-20)32-9-7-21(8-10-32)31(4)11-12-34/h5-6,13-17,21,34H,7-12H2,1-4H3,(H,27,29,30)
InChI Key CVLXNRIQVFIVGY-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Immunopharmacology Comments
Compound 18e inhibits JAK-mediated cytokine-induced (IL-2, IL-6, GM-CSF) STAT3/5 phosphorylation in human PBMCs:
IL-2 induced pSTAT5 via JAK1/3 IC50 112 nM
IL-6 induced pSTAT3 via JAK1 IC50 94 nM
GM-CSF induced pSTAT5 via JAK2 IC50 10 nM